Inhibition of inducible nitric oxide synthase attenuates established acute cardiac allograft rejection

Annals of Thoracic Surgery

Volumn 62, Issue 2, 1996, Pages 378-385

  Worrall, Neil K ^a,b   Misko, Thomas P ^b   Sullivan, Patrick M ^b   Hui, Jia J ^b   Ferguson Jr , T Bruce ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; DEXAMETHASONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFICACY; ENZYME INHIBITION; GRAFT REJECTION; HEART TRANSPLANTATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT;

EID: 0030218114     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00311-6     Document Type: Article

References (30)

1. 1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-42.
2. 2. Stuehr DJ, Nathan CF. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989;169:1543-55.
3. 3. Worrall NK, Lazenby WD, Misko TP, et al. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 1995;181:63-70.
4. 4. Misko TP, Moore WM, Kasten TP, et al. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 1993;233:119-25.
5. 5. Worrall NK, Pyo RT, Alexander DG, Misko TP, Lazenby WD, Ferguson TB Jr. Nitric oxide mediates myocardial contractile and electrophysiological dysfunction during early cardiac allograft rejection. Surg Forum 1995;46:239-41.
6. 6. Worrall NK, C hang K, Suau GM, et al. Inhibition of inducible nitric oxide synthase prevents myocardial and systemic vascular barrier dysfunction during early cardiac allograft rejection. Circ Res 1996;78:769-79.
7. 7. Lewis NP, Tsao PS, Rickenbacher PR, et al. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 1996;93:720-9.
8. 8. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969;57:225-9.
9. 9. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993;214:11-6.
10. 10. Worrall NK, Misko TP, Sullivan PM, Hui J-J, Rodi CP, Ferguson TB Jr. Corticosteroids inhibit expression of inducible nitric oxide synthase during acute cardiac allograft rejection. Transplantation 1996;61:324-8.
11. 11. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990;87:682-5.
12. 12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-54.
13. 13. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
14. 14. Billingham ME. Diagnosis of cardiac rejection by endomyocardial biopsy. Heart Transplant 1981;1:25-30.
15. 15. Yang X, Chowdhury N, Cai B, et al. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest 1994;94:714-21.
16. 16. Wu CJ, Lovett M, Wong-Lee J, et al. Cytokine gene expression in rejecting cardiac allografts. Transplantation 1992;54: 326-32.
17. 17. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 1986;232:1629-32.
18. 18. Hui JY, Taylor SL. Inhibition of in vivo histamine metabolism in rats by foodborne and pharmacologic inhibitors of diamine oxidase, histamine N-methyltransferase, and monoamine oxidase. Toxicol Appl Pharmacol 1985;81:241-9.
19. 19. Kumari K, Umar S, Bansal V, Sahib MK. Inhibibition of diabetes-associated complications by nucleophilic compounds. Diabetes 1991;40:1079-84.
20. 20. Lancaster JR, Langrehr JM, Bergonia HA, Murase N, Simmons RL, Hoffman RA. EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J Biol Chem 1992;267:10994-8.
21. 21. Wagoner LE, Zhao L, Bishop DK, Chan S, Xu S, Barry WH. Lysis of adult ventricular myocytes by cells infiltrating rejecting murine cardiac allografts. Circulation 1996;93: 111-9.
22. 22. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-4.
23. 23. Shiraishi T, DeMeester SR, Worrall NK, et al. Inhibition of inducible nitric oxide synthase ameliorates rat lung allograft rejection. J Thorac Cardiovasc Surg 1995:110:1449-60.
24. 24. Worrall NK, Boasquevisque CH, Misko TP, Sullivan PM, Patterson GA, Ferguson TB Jr. Expression of inducible nitric oxide synthase during acute lung allograft rejection [Abstract]. J Heart Lung Transplant 1996;15:S62.
25. 25. Gorczynski RM, Rossi-Bergman B, Sullivan B, Chen Z. Role of reactive nitrogen intermediates in the regulation of allogeneic skin graft survival in mice after portal vein pretransplant transfusion. Transplantation 1995;60:707-13.
26. 26. Langrehr JM, Murase N, Markus PM, et al. Nitric oxide production in host-versus- graft and graft-versus-host reactions in the rat. J Clin Invest 1992;90:679-83.
27. 27. Tanaka S, Kamiike W, Ito T, et al. Generation of nitric oxide as a rejection marker in rat pancreas transplantation. Transplantation 1995;60:713-7.
28. 28. Devlin J, Palmer RMJ, Gonde CE, et al. Nitric oxide generation: a predictive parameter of acute allograft rejection. Transplantation 1994;58:592-5.
29. 29. Weiss G, Schwaighofer H, Herold M, et al. Nitric oxide formation as a predictive parameter for acute graft-versus-host disease after human allogeneic bone marrow transplantation. Transplantation 1995;60:1239-44.
30. 30. Winlaw DS, Schyvens CG, Smythe GA, et al. Selective inhibition of nitric oxide production during cardiac allograft rejection causes a small increase in graft survival. Transplantation 1995;60:77-82.